13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease.
- DOI
- 10.1101/2025.04.30.651373
- Published
- 2025 May 3
- Container
- bioRxiv : the preprint server for biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1101/2025.04.30.651373,
title = {13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease.},
author = {Mekkittikul M and Zhu C and Danna BT and Zuo X and Rios A and Yang K and Villanueva M and Agarwal D and Castro D and Gu X and Strofs AR and Shirihai OS and Stiles L and Frautschy SA and Oscarsson J and Esterline RL and Cole GM and Divakaruni AS},
year = {2025},
journal = {bioRxiv : the preprint server for biology},
doi = {10.1101/2025.04.30.651373},
url = {https://doi.org/10.1101/2025.04.30.651373}
}RIS
TY - JOUR TI - 13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease. AU - Mekkittikul M AU - Zhu C AU - Danna BT AU - Zuo X AU - Rios A AU - Yang K AU - Villanueva M AU - Agarwal D AU - Castro D AU - Gu X AU - Strofs AR AU - Shirihai OS AU - Stiles L AU - Frautschy SA AU - Oscarsson J AU - Esterline RL AU - Cole GM AU - Divakaruni AS PY - 2025 JO - bioRxiv : the preprint server for biology DO - 10.1101/2025.04.30.651373 UR - https://doi.org/10.1101/2025.04.30.651373 ER -
APA
M, M., C, Z., BT, D., X, Z., A, R., K, Y., M, V., D, A., D, C., X, G., AR, S., OS, S., L, S., SA, F., J, O., RL, E., GM, C., & AS, D. (2025). 13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.04.30.651373
Source records
- pubmed · retrieved 2026-09-27T15:02:06.696Z